cancerappy 1

Be our partner

We continually innovate and improve our technology platform to more accurately predict factors relevant to cancer drug development.

We are happy to explore research or development collaborations.

Let´s talk

Flexible agreements and partnerships

We offer flexible agreements that can range from any combination of de novo discovery to lead optimization

Range of offers

We identify new potential inhibitors, determine the possible mechanism of action, look for the most optimal combinations between drugs, and help develop other solutions such as ADCs, PROTACs and nanoparticles.

Academic Collaborations

We collaborate with academic institutions on research projects that could benefit from our technology and experience.

CRO Parterships

We establish strategic partnerships with CROs and service providers who can provide reliable and innovative offerings that complement our tech platform capabilities.

Some of our academic partners